[The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
D000328:Adult; D000368:Aged; D000738:Androsterone / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002087:Butyrates / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007456:Iodine Isotopes; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood*; D014304:Triolein
D000924:Anticholesteremic Agents; D002087:Butyrates; D007456:Iodine Isotopes; D008055:Lipids; D008074:Lipoproteins; D014280:Triglycerides; D014304:Triolein; D002784:Cholesterol; D000738:Androsterone
Die Wirkung des Athyl-chlorophenoxyisobutyrats auf die Serumlipide bei Koronarsklerose.